& Holscher, C
Twice-daily application increases peptide exposure but also increases product consumption and potential for irritation
However, in February 2025, the FDA confirmed that shortages of both Ozempic and its weight loss counterpart, Wegovy, had been resolved, reducing the need for compounded alternatives
demonstrated that a combined treatment of GIP and GLP-1 for 12 days in Swiss mice resulted in increased weight loss compared to treatment with exendin-4 alone but had no additional blood glucose regulation benefits (33)
But these medications not only help with weight loss, but give cardiac benefits, help with blood pressure, help cholesterol and kill sleep apnea. Another barrier is a 2003 law that prohibits Medicare from covering weight loss drugs, cutting off a huge group of potential patients
Inflammatory regulation by driving microglial M2 polarization: neuroprotective effects of cannabinoid receptor-2 activation in intracerebral hemorrhage
